Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Negrin

Showing results (111-120 of 260) with videos related to

Pageof 26
Sort By:
Blood|October 31, 2007
Differential impact of mammalian target of rapamycin inhibition on CD4+CD25+Foxp3+ regulatory T cells compared with conventional CD4+ T cellsRobert Zeiser, Dennis B Leveson-Gower, Elizabeth A Zambricki, et al.
Experimental Hematology|August 1, 1995
Enrichment of bone marrow and blood progenitor (CD34+) cells by density gradients with sufficient yields for transplantationJ R Schriber, S Dejbakhsh-Jones, C R Kusnierz-Glaz, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 20, 2008
Impact of mammalian target of rapamycin inhibition on lymphoid homing and tolerogenic function of nanoparticle-labeled dendritic cells following allogeneic hematopoietic cell transplantationWilfried Reichardt, Christoph Dürr, Dominik von Elverfeldt, et al.
Blood|September 14, 2013
Mast cells suppress murine GVHD in a mechanism independent of CD4+CD25+ regulatory T cellsDennis B Leveson-Gower, Emanuela I Sega, Janet Kalesnikoff, et al.
Blood|June 12, 2015
Treatment with agonistic DR3 antibody results in expansion of donor Tregs and reduced graft-versus-host diseaseByung-Su Kim, Hidekazu Nishikii, Jeanette Baker, et al.
Clinical Transplants|January 1, 1990
Bone marrow transplantation for hematologic malignancies: the Stanford experienceN J Chao, M D Amylon, G D Long, et al.
International Journal of Cancer|December 18, 2001
Hodgkin disease-derived cell lines expressing ubiquitous mitochondrial creatine kinase show growth inhibition by cyclocreatine treatment independent of apoptosisM Kornacker, U Schlattner, T Wallimann, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 24, 2001
CD31 mismatching affects marrow transplantation outcomeF C Grumet, D D Hiraki, Brown BWM, et al.
Blood|October 9, 2014
CD4+ invariant natural killer T cells protect from murine GVHD lethality through expansion of donor CD4+CD25+FoxP3+ regulatory T cellsDominik Schneidawind, Antonio Pierini, Maite Alvarez, et al.
Blood|July 2, 2016
TNF-α priming enhances CD4+FoxP3+ regulatory T-cell suppressive function in murine GVHD prevention and treatmentAntonio Pierini, William Strober, Caitlin Moffett, et al.
Pageof 26

Showing results (111-120 of 260) with videos related to

Sort By:
Pageof 26
Blood|October 31, 2007
Differential impact of mammalian target of rapamycin inhibition on CD4+CD25+Foxp3+ regulatory T cells compared with conventional CD4+ T cellsRobert Zeiser, Dennis B Leveson-Gower, Elizabeth A Zambricki, et al.
Experimental Hematology|August 1, 1995
Enrichment of bone marrow and blood progenitor (CD34+) cells by density gradients with sufficient yields for transplantationJ R Schriber, S Dejbakhsh-Jones, C R Kusnierz-Glaz, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 20, 2008
Impact of mammalian target of rapamycin inhibition on lymphoid homing and tolerogenic function of nanoparticle-labeled dendritic cells following allogeneic hematopoietic cell transplantationWilfried Reichardt, Christoph Dürr, Dominik von Elverfeldt, et al.
Blood|September 14, 2013
Mast cells suppress murine GVHD in a mechanism independent of CD4+CD25+ regulatory T cellsDennis B Leveson-Gower, Emanuela I Sega, Janet Kalesnikoff, et al.
Blood|June 12, 2015
Treatment with agonistic DR3 antibody results in expansion of donor Tregs and reduced graft-versus-host diseaseByung-Su Kim, Hidekazu Nishikii, Jeanette Baker, et al.
Clinical Transplants|January 1, 1990
Bone marrow transplantation for hematologic malignancies: the Stanford experienceN J Chao, M D Amylon, G D Long, et al.
International Journal of Cancer|December 18, 2001
Hodgkin disease-derived cell lines expressing ubiquitous mitochondrial creatine kinase show growth inhibition by cyclocreatine treatment independent of apoptosisM Kornacker, U Schlattner, T Wallimann, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 24, 2001
CD31 mismatching affects marrow transplantation outcomeF C Grumet, D D Hiraki, Brown BWM, et al.
Blood|October 9, 2014
CD4+ invariant natural killer T cells protect from murine GVHD lethality through expansion of donor CD4+CD25+FoxP3+ regulatory T cellsDominik Schneidawind, Antonio Pierini, Maite Alvarez, et al.
Blood|July 2, 2016
TNF-α priming enhances CD4+FoxP3+ regulatory T-cell suppressive function in murine GVHD prevention and treatmentAntonio Pierini, William Strober, Caitlin Moffett, et al.
Pageof 26